NexImmune Company

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.
Technology: Atrificial Vectors and Immune Cells
Industry: Atrificial Vectors and Immune Cells
Headquarters: Gaithersburg, Maryland, United States
Founded Date: 2011-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 7
Total Funding: 109800000
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-02-17
Last Funding Type: Post-IPO Equity

Visit Website
kcarter@neximmune.com
Register and Claim Ownership